Literature DB >> 2268298

The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo.

J C Holder1, V A Zammit, D S Robinson.   

Abstract

The removal from the blood and the uptake by the liver of injected very-low-density lipoprotein (VLDL) preparations that had been radiolabelled in their apoprotein and cholesteryl ester moieties was studied in lactating rats. Radiolabelled cholesteryl ester was removed from the blood and taken up by the liver more rapidly than sucrose-radiolabelled apoprotein. Near-maximum cholesteryl ester uptake by the liver occurred within 5 min of the injection of the VLDL. At this time, apoprotein B uptake by the liver was only about 25% of the maximum. Maximum uptake of the injected VLDL apoprotein B label was not achieved until at least 15 min after injection, by which time the total uptakes of cholesteryl ester and apoprotein B label were very similar. The results suggest that preferential uptake of the lipoprotein cholesteryl ester by the liver occurred before endocytosis of the entire lipoprotein complex. The fate of the injected VLDL cholesteryl ester after its uptake by the liver was also monitored. Radiolabel associated with the hepatic cholesteryl ester fraction fell steadily from its early maximum level, the rate of fall being faster and more extensive when the fatty acid, rather than the cholesterol, moiety of the ester was labelled. By 30 min after the injection of VLDL containing [3H]cholesteryl ester, over one-third of the injected label was already present as [3H]cholesterol in the liver. When VLDL containing cholesteryl [14C]oleate was injected, a substantial proportion (about 25%) of the injected radiolabelled fatty acid appeared in the hepatic triacylglycerol fraction within 60 min: very little was present in the plasma triacylglycerol fraction at this time.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268298      PMCID: PMC1149770          DOI: 10.1042/bj2720735

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

Review 1.  Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism.

Authors:  R J Havel; R L Hamilton
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

2.  The uptake of the apoprotein and cholesteryl ester of high-density lipoproteins by the perfused rat liver.

Authors:  C M Arbeeny; V A Rifici; H A Eder
Journal:  Biochim Biophys Acta       Date:  1987-01-13

Review 3.  Compartmentalization of cholesterol in hepatic and intestinal cells: implications for bile and lipoprotein secretion.

Authors:  E F Stange
Journal:  Biochem Soc Trans       Date:  1987-04       Impact factor: 5.407

4.  Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats.

Authors:  T Murase; H Itakura
Journal:  Atherosclerosis       Date:  1981-06       Impact factor: 5.162

5.  Lipoprotein biosynthesis and metabolism.

Authors:  R J Havel
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

6.  The role of lipoprotein lipase in the assimilation of cholesteryl linoleyl ether by cultured cells incubated with labeled chylomicrons.

Authors:  G Friedman; T Chajek-Shaul; O Stein; T Olivecrona; Y Stein
Journal:  Biochim Biophys Acta       Date:  1981-10-23

7.  Uptake of chylomicron [3H]cholesteryl linoleyl ether by mesenchymal rat heart cell cultures.

Authors:  T Chajek-Shaul; G Friedman; G Halperin; O Stein; Y Stein
Journal:  Biochim Biophys Acta       Date:  1981-10-23

8.  Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by Hep G2 cells.

Authors:  F Rinninger; R C Pittman
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Function of hepatic triglyceride lipase in lipoprotein metabolism.

Authors:  J Grosser; O Schrecker; H Greten
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

10.  A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters.

Authors:  R C Pittman; T P Knecht; M S Rosenbaum; C A Taylor
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

View more
  7 in total

Review 1.  Role of insulin in hepatic fatty acid partitioning: emerging concepts.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

2.  Selective labelling of hepatic fatty acids in vivo. Studies on the synthesis and secretion of glycerolipids in the rat.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice.

Authors:  Zhi H Huang; Catherine A Reardon; Papasani V Subbaiah; Godfrey S Getz; Theodore Mazzone
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

4.  Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways.

Authors:  Zhi Hua Huang; Richard D Minshall; Theodore Mazzone
Journal:  J Biol Chem       Date:  2009-09-18       Impact factor: 5.157

5.  Effects of insulin treatment of diabetic rats on hepatic partitioning of fatty acids between oxidation and esterification, phospholipid and acylglycerol synthesis, and on the fractional rate of secretion of triacylglycerol in vivo.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Sources of triacylglycerol accumulation in livers of rats fed a cholesterol-supplemented diet.

Authors:  C H Liu; M T Huang; P C Huang
Journal:  Lipids       Date:  1995-06       Impact factor: 1.880

7.  Monitoring of changes in hepatic fatty acid and glycerolipid metabolism during the starved-to-fed transition in vivo. Studies on awake, unrestrained rats.

Authors:  A M Moir; V A Zammit
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.